Rehabilitation After Covid19-Clinical Results and Predictive Factors

NCT04896905 | Completed

• 1 other identifier: Covid19_2020
• Study Type: observational
• Target: 101
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of the study is to gain insight into the rehabilitation process and predictive factors for the outcome after rehabilitation in three patient groups:

1. 1.SARS-CoV-2-positive patients in the isolation ward
2. 2.Post-Covid-19 patients
3. 3.Control group; matched for gender, age and co-morbidity

Conditions

Covid19

Keywords

Covid19; Sars-CoV-2; Rehabilitation; Outcome; Predictive factors

Outcome Measures

Primary Outcomes (4)

• Mobility

  Timed Up and Go-Test TUG (Seconds; less=better, normal \<10 Sec.)

  Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)

• Functional Independence Measurement-Level (FIM)

  FIM at entry and discharge (min 18, max 126 points; higher level= better functioning; )

  Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)

• Promis-10 (Promis= Patient reported outcome measurement information system)

  Level of patient self rated functioning in daily activities (higher level= better self related functioning)

  Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)

• Quality of life

  EQ5D- VAS (0-100; higher level = better quality of life)

  Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)

Study Arms (3)

Isolation group with active Covid19

Patients assigned to rehab which had to be treated in isolation wards dur to active disease

Other: Rehabilitation

Post-Covid-group

Patients assigned to rehab after active disease, still having restrictions in activity and particiaption

Other: Rehabilitation

Control group

Pateints assigned to rehabilitation in the same time period without any signs of Sars-coV-2 infection

Other: Rehabilitation

Interventions

Rehabilitation OTHER

Rehabilitative procedures in isolation ward

Control group; Isolation group with active Covid19; Post-Covid-group

Eligibility Criteria

• Age: 40 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All patients referred to rehabilitation between March and June 2020 either with active Covid19, post-Covid-State oor other indications for inpatient rehab (eg. muskuloskelettal, cancer, pulmonary diseases not related to Covid19)

You may qualify if:

• Patients assigned to rehab
• Written informed consent

You may not qualify if:

• not able to fill in questionnaires in German

Sponsors & Collaborators

• Klinik Valens: lead

Study Sites (1)

Rehabilitationszentrum Klinik Valens

Valens, Canton of St. Gallen, CH- 7317, Switzerland

Location

MeSH Terms

Conditions

COVID-19

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Aftercare; Continuity of Patient Care; Patient Care; Therapeutics; Health Services; Health Care Facilities Workforce and Services

Study Officials

• Steffi Petzold, MMed

  Kliniken Valens

  PRINCIPAL INVESTIGATOR

• Roisin Carney, PT, cand MSc

  Kliniken Valens

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: OTHER
• Target Duration: 4 Weeks
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Chief Medical Officer, Clinical Professor

Study Record Dates

• First Submitted: May 19, 2021
• First Posted: May 21, 2021
• Study Start: October 1, 2020
• Primary Completion: February 28, 2021
• Study Completion: May 18, 2021
• Last Updated: May 21, 2021

Record last verified: 2021-05

Data Sharing

• IPD Sharing: Will not share

Locations

CH (1)